BWIN
The Baldwin Insurance Group, Inc.
31.80$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 23.4% | 26.4% | 27.1% | 30.9% | 33.3% | 29.0% | 29.8% | 33.2% | 29.2% | 31.1% | 26.8% | 29.9% | |
| 2.3% | 3.3% | 3.2% | 5.7% | 5.1% | 4.2% | 2.3% | 2.8% | 2.4% | 3.2% | 2.5% | 3.0% | |
| 2.3% | 3.3% | 3.2% | 5.7% | 9.7% | 4.2% | 2.3% | 2.8% | 2.4% | 3.2% | 2.5% | 3.0% | |
| 17.4% | 17.9% | 20.0% | 20.7% | 18.5% | 19.9% | 20.8% | 22.5% | 9.1% | 21.7% | 18.8% | 19.7% | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 41.5% | 40.3% | 40.2% | 38.4% | 39.9% | 40.0% | 39.8% | 38.0% | 40.0% | 39.3% | 44.6% | 43.0% | |
| 30.5% | 29.1% | 28.5% | 26.8% | 27.4% | 27.0% | 26.4% | 24.8% | 26.8% | 25.3% | 25.0% | 23.5% | |
| 68.6% | 70.9% | 69.5% | 71.6% | 70.7% | 71.5% | 70.5% | 71.9% | 70.3% | 71.9% | 73.9% | 77.0% | |
| 23.3% | 29.5% | 30.0% | 31.4% | 29.1% | 29.9% | 26.3% | 26.9% | 25.3% | 26.7% | 24.8% | 27.9% | |
| 3.7% | 7.0% | 7.5% | 6.4% | 6.6% | 4.9% | 2.0% | 0.9% | 1.2% | 1.0% | 2.6% | 2.6% | |
| 16.6% | 17.7% | 19.5% | 22.1% | 18.7% | 20.2% | 2.5% | 1.9% | 1.8% | 20.0% | 1.6% | 1.6% | |
| 37.8% | 37.4% | 37.1% | 38.1% | 39.5% | 39.6% | 42.2% | 43.0% | 43.1% | 43.3% | 39.5% | 39.7% | |
| 17.3% | 16.0% | 17.0% | 16.1% | 16.8% | 16.5% | 17.5% | 16.9% | 16.3% | 15.5% | 16.2% | 14.3% | |
| -4.5% | -5.3% | -4.7% | -5.0% | -5.4% | -6.0% | -5.6% | -5.4% | -5.8% | -6.3% | -4.6% | -6.0% | |
| 1.8% | 1.7% | 1.9% | 1.7% | 1.8% | 1.8% | 2.0% | 1.8% | 1.8% | 1.8% | 1.2% | 1.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.